206 related articles for article (PubMed ID: 26902473)
1. Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium.
Jia J; Davis CM; Zhang W; Edin ML; Jouihan S; Jia T; Bradbury JA; Graves JP; DeGraff LM; Lee CR; Ronnekleiv O; Wang R; Xu Y; Zeldin DC; Alkayed NJ
Exp Neurol; 2016 May; 279():75-85. PubMed ID: 26902473
[TBL] [Abstract][Full Text] [Related]
2. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart.
Edin ML; Wang Z; Bradbury JA; Graves JP; Lih FB; DeGraff LM; Foley JF; Torphy R; Ronnekleiv OK; Tomer KB; Lee CR; Zeldin DC
FASEB J; 2011 Oct; 25(10):3436-47. PubMed ID: 21697548
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA
PLoS One; 2017; 12(3):e0174137. PubMed ID: 28328948
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice.
Li R; Xu X; Chen C; Yu X; Edin ML; Degraff LM; Lee CR; Zeldin DC; Wang DW
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):68-78. PubMed ID: 23041291
[TBL] [Abstract][Full Text] [Related]
5. Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice.
Deng Y; Edin ML; Theken KN; Schuck RN; Flake GP; Kannon MA; DeGraff LM; Lih FB; Foley J; Bradbury JA; Graves JP; Tomer KB; Falck JR; Zeldin DC; Lee CR
FASEB J; 2011 Feb; 25(2):703-13. PubMed ID: 21059750
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-specific CYP2J2 overexpression attenuates age-related insulin resistance.
Yang Y; Dong R; Chen Z; Hu D; Fu M; Tang Y; Wang DW; Xu X; Tu L
Aging Cell; 2018 Apr; 17(2):. PubMed ID: 29318723
[TBL] [Abstract][Full Text] [Related]
7. Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.
Lee CR; Imig JD; Edin ML; Foley J; DeGraff LM; Bradbury JA; Graves JP; Lih FB; Clark J; Myers P; Perrow AL; Lepp AN; Kannon MA; Ronnekleiv OK; Alkayed NJ; Falck JR; Tomer KB; Zeldin DC
FASEB J; 2010 Oct; 24(10):3770-81. PubMed ID: 20495177
[TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
Zhang W; Otsuka T; Sugo N; Ardeshiri A; Alhadid YK; Iliff JJ; DeBarber AE; Koop DR; Alkayed NJ
Stroke; 2008 Jul; 39(7):2073-8. PubMed ID: 18369166
[TBL] [Abstract][Full Text] [Related]
9. Role of endothelial soluble epoxide hydrolase in cerebrovascular function and ischemic injury.
Zhang W; Davis CM; Edin ML; Lee CR; Zeldin DC; Alkayed NJ
PLoS One; 2013; 8(4):e61244. PubMed ID: 23585883
[TBL] [Abstract][Full Text] [Related]
10. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta.
Cizkova K; Tauber Z
Acta Histochem; 2018 Aug; 120(6):513-519. PubMed ID: 29908721
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack.
Alkayed NJ; Goyagi T; Joh HD; Klaus J; Harder DR; Traystman RJ; Hurn PD
Stroke; 2002 Jun; 33(6):1677-84. PubMed ID: 12053011
[TBL] [Abstract][Full Text] [Related]
13. CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype.
Abraham NG; Sodhi K; Silvis AM; Vanella L; Favero G; Rezzani R; Lee C; Zeldin DC; Schwartzman ML
Hypertension; 2014 Dec; 64(6):1352-61. PubMed ID: 25245389
[TBL] [Abstract][Full Text] [Related]
14. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 Epoxygenase 2J2 Protects Against Lung Ischemia/Reperfusion Injury by Activating the P13K/Akt/GSK-3-β/NF-kB Signaling Pathway During Deep Hypothermic Low Flow in Mice.
Yang Y; Wang J; Peng W; Shu Y; Mo X
J Surg Res; 2020 Sep; 253():8-17. PubMed ID: 32305498
[TBL] [Abstract][Full Text] [Related]
16. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.
Shahabi P; Siest G; Meyer UA; Visvikis-Siest S
Pharmacol Ther; 2014 Nov; 144(2):134-61. PubMed ID: 24882266
[TBL] [Abstract][Full Text] [Related]
17. Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.
Delozier TC; Kissling GE; Coulter SJ; Dai D; Foley JF; Bradbury JA; Murphy E; Steenbergen C; Zeldin DC; Goldstein JA
Drug Metab Dispos; 2007 Apr; 35(4):682-8. PubMed ID: 17220242
[TBL] [Abstract][Full Text] [Related]
18. The role of cytochrome P450 epoxygenases in retinal angiogenesis.
Capozzi ME; McCollum GW; Penn JS
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4253-60. PubMed ID: 24917142
[TBL] [Abstract][Full Text] [Related]
19. Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population.
Arun Kumar AS; Kumar SS; Umamaheswaran G; Kesavan R; Balachandar J; Adithan C
Pharmacol Rep; 2015 Feb; 67(1):97-101. PubMed ID: 25560582
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in genes involved in vasoactive eicosanoid synthesis affect cardiovascular risk in renal transplant recipients.
Gervasini G; Luna E; Garcia-Pino G; Azevedo L; Mota-Zamorano S; José Cubero J
Curr Med Res Opin; 2018 Feb; 34(2):247-253. PubMed ID: 29022765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
